Skip to main content
AMCP Nexus 2024 Main banner
Back

Managed Care Research in Action

(R2) Unlocking the Power of Precision Medicine: Biomarker-Driven Oncology Care

Tuesday, October 15, 2024
10:15 AM – 11:45 AM PT
Location: 114
ACPE UAN:N/A | Contact Hours: N/A | Activity Type: N/A
This session is not accredited for continuing pharmacy education credit

Did you know that only 36% of NSCLC patients receive the appropriate treatment, with even lower percentages for other cancers? Join us for a session that examines the critical leakage points leading to these alarming statistics and explores how managed care strategies can effectively close these gaps.

We will discuss best practice recommendations to optimize biomarker testing in oncology. Actionable strategies have been identified to address current challenges through a collaborative approach involving oncology experts, biomarker specialists, managed care professionals, and patient advocates.

This session will offer practical recommendations and real-world examples for supporting evidence-based biomarker testing strategies. By the end, attendees will be equipped with powerful methods to enhance biomarker-driven oncology care, improve treatment selection, and ensure the timely implementation of precision medicine within managed care settings. Don’t miss this opportunity to make a tangible impact on cancer care outcomes.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Describe the impact of evidence-based biomarker testing on patient outcomes in oncology.
  2. Recognize the current gaps in the precision oncology pathway that may lead to suboptimal treatment selection.
  3. Identify practical steps for incorporating biomarker testing best practices into managed care settings.
  4. Assess opportunities for quality improvement in biomarker testing in managed care settings.